Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New symptom may help identify sleep apnea in older women

  • Feeling blue and seeing blue: Sadness may impair color perception

  • Risk of cognitive impairment in children born prematurely may be predicted using MRI after birth

  • Language acquisition: From sounds to the meaning

  • Forensic examiners pass the face matching test

  • Bisexual and questioning women have higher risk of eating disorders

  • Psychological consequences remain profound in coastal areas of Tohoku

  • How anesthesia may fight lung infections: Mouse study

  • Researchers develop a likely new combo treatment for the deadliest form of brain cancer

  • Antipsychotics inappropriately prescribed to people with intellectual disabilities

  •